Quadro Acquisition One Corp.: Nasdaq/NYSE listing notice — Kismet Acquisition Two receives Nasdaq deficiency notice for audit committee composition

Quadro Acquisition One Corp.

Received deficiency notice on Feb 13, 2023 due to director Verdi Israelyan's resignation on Sep 5, 2022.
Audit committee now has two members; Nasdaq rule requires three.
Cure period until earlier of next annual meeting or Sep 5, 2023 (or Mar 6, 2023 if meeting before then).
Company expects to regain compliance before the cure period expires.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.97

Quadro Acquisition One Corp. received a nasdaq deficiency notice notice regarding audit committee (rules 5605, 5605(c)(4)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: audit committee
Rules: 5605, 5605(c)(4)

Exact text from the filing

February 13, 2023, Kismet Acquisition Two Corp., a Cayman Islands exempted company (the “Company”), received a deficiency notice from the Nasdaq Stock Market (“Nasdaq”) notifying the Company that, as a result of the resignation of Verdi Israelyan from the board of directors of the Company (the “Board”) and the audit committee of the Board (“Audit Committee”) on September 5, 2022, the Company is no longer in compliance with the continued listing requirements set forth in Nasdaq Listing Rule 5605 regarding the composition of the Audit Committee, because the Audit Committee is now comprised of on

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001213900-23-012450

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.